Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 9, 2013, Pages 1074-1081

  Feuth, Thijs ^a   Arends, Joop E ^a   Lieveld, Faydra I ^a   Mundt, Marco W ^a,b   Hoepelman, Andy IM ^a   Siersema, Peter D ^a   Van Erpecum, Karel J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Flevohospital ^*  (Netherlands)

Author keywords

Hepatitis B; Hepatitis C; Liver cirrhosis; Transient elastography

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIGESTIVE TRACT PARAMETERS; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; COINFECTION; DECISION MAKING; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; WATCHFUL WAITING;

EID: 84883005575     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.819441     Document Type: Article

References (28)

1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20 (Pubitemid 24166476)
2. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371: 838-51 (Pubitemid 351323895)
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection. J Hepatol 2011;55:245-64
4. European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012;57:167-85
5. Castera L, Bedossa P. How to assess liver fibrosis in chronic hepatitis C: Serum markers or transient elastography vs. liver biopsy? Liver Int 2011;31:13-17
6. Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009;15:2190-203
7. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13 (Pubitemid 38091720)
8. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54 (Pubitemid 40066382)
9. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut 2006;55:403-8 (Pubitemid 43268281)
10. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: A meta-Analysis. Gastroenterology 2008;134:960-74
11. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-73 (Pubitemid 46999083)
12. Fransen van de Putte D, Blom R, van Soest H, Mundt M, Verveer C, Arends J, et al. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice. Ann Hepatol 2011;10:469-76
13. Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2011;60:977-84
14. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128: 343-50 (Pubitemid 40439195)
15. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008;23:512-20
16. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36:S237-44 (Pubitemid 35253486)
17. De Francesco R, Migliaccio G. Challenges and successes in developing new therapies for hepatitis C. Nature 2005;436: 953-60 (Pubitemid 41191671)
18. Gane E. Future hepatitis C virus treatment: Interferonsparing combinations. Liver Int 2011;31:62-7
19. Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011;364:2405-16
20. Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011;364:1195-206
21. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: A meta-Analysis of observational studies. Ann Intern Med 2013;158:329-37
22. Vispo E, Barreiro P, Del Valle J, Maida I, de Ledinghen V, Quereda C, et al. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir Ther 2009;14:187-93
23. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002;122:1303-13 (Pubitemid 34465173)
24. Castera L, Foucher J, Bernard PH, Carvalho F, Allaix D, Merrouche W, et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 2010;51:828-35
25. Friedrich-Rust M, Zeuzem S. Reproducibility and limitations of transient elastography. Liver Int 2009;29:619-20
26. Boursier J, Konate A, Gorea G, Reaud S, Quemener E, Oberti F, et al. Reproducibility of liver stiffness measurement by ultrasonographic elastometry. Clin Gastroenterol Hepatol 2008;6:1263-9
27. Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 2008;48:1718-23
28. Lebray P, Varnous S, Charlotte F, Varaut A, Poynard T, Ratziu V. Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency. Hepatology 2008;48:2089